PALI (Palisade Bio) Short-term investments

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PALI Palisade Bio Inc PALI
29 GF Score
Price $1.64
! 2 Warning Signs
View Full Analysis

What is Palisade Bio Short-term investments?

Short-term investments only applies to insurance companies.

PALI
29GF Score
Palisade Bio Inc PALI
Short-term investments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Palisade Bio Business Description

Address 4600 South Syracuse Street, Suite 900, Denver, CO, USA, 80237
Palisade Bio Inc. is a clinical-stage biopharmaceutical company based in the United States that develops oral therapeutics for inflammatory and immune-mediated diseases. Its lead candidate, PALI-2108, is an orally administered, colon-specific prodrug of a phosphodiesterase-4 (PDE4) inhibitor being developed for ulcerative colitis and Crohn's disease, with the aim of delivering drug activity locally in the gastrointestinal tract while limiting systemic exposure. The company also has earlier-stage programs, including PALI-1908, and has explored treatments targeting intestinal barrier integrity. As a clinical-stage company, Palisade Bio does not yet market approved products and generates no product revenue; it funds operations primarily through equity financings and capital markets activity. Its activities center on preclinical and clinical development, regulatory interactions, and intellectual property protection, with the United States as its principal market and development focus.
29GF Score

Get the complete analysis for PALI

Short-term investments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.64
Price